NHS England completed a pilot for hybrid closed loop technology for patients with type 1 diabetes last year. The findings have been with the National Institute for Health Care Excellence (NICE). NICE’s role is to produce guidance on good practice, based on the best available evidence of both clinical and cost effectiveness. Responsibility for the delivery of services and the implementation of NICE recommendations rests with the appropriate integrated care board (ICB). ICBs must pay due regard to NICE guidance however local decision making applies in terms of deciding the extent to which they utilise their funding to implement the recommendation or not.